Logo image of UB5.DE

US BANCORP (UB5.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:UB5 - US9029733048 - Common Stock

42.49 EUR
+1.22 (+2.94%)
Last: 11/27/2025, 7:00:00 PM
Fundamental Rating

4

Overall UB5 gets a fundamental rating of 4 out of 10. We evaluated UB5 against 108 industry peers in the Banks industry. UB5 has a bad profitability rating. Also its financial health evaluation is rather negative. UB5 is not valued too expensively and it also shows a decent growth rate. Finally UB5 also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

UB5 had positive earnings in the past year.
UB5 had a positive operating cash flow in the past year.
UB5 had positive earnings in each of the past 5 years.
UB5 had a positive operating cash flow in each of the past 5 years.
UB5.DE Yearly Net Income VS EBIT VS OCF VS FCFUB5.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

UB5 has a Return On Assets (0.87%) which is comparable to the rest of the industry.
UB5 has a Return On Equity (10.09%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.87%
ROE 10.09%
ROIC N/A
ROA(3y)0.82%
ROA(5y)0.92%
ROE(3y)10.02%
ROE(5y)10.52%
ROIC(3y)N/A
ROIC(5y)N/A
UB5.DE Yearly ROA, ROE, ROICUB5.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

UB5's Profit Margin of 21.62% is in line compared to the rest of the industry. UB5 outperforms 45.37% of its industry peers.
UB5's Profit Margin has declined in the last couple of years.
UB5 does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 21.62%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.56%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
UB5.DE Yearly Profit, Operating, Gross MarginsUB5.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

2

2. Health

2.1 Basic Checks

UB5 does not have a ROIC to compare to the WACC, probably because it is not profitable.
UB5 has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for UB5 has been increased compared to 5 years ago.
UB5 has a worse debt/assets ratio than last year.
UB5.DE Yearly Shares OutstandingUB5.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
UB5.DE Yearly Total Debt VS Total AssetsUB5.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

2.2 Solvency

UB5 has a debt to FCF ratio of 6.40. This is a slightly negative value and a sign of low solvency as UB5 would need 6.40 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.40, UB5 belongs to the top of the industry, outperforming 87.04% of the companies in the same industry.
A Debt/Equity ratio of 1.23 is on the high side and indicates that UB5 has dependencies on debt financing.
UB5 has a better Debt to Equity ratio (1.23) than 71.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF 6.4
Altman-Z N/A
ROIC/WACCN/A
WACC14.05%
UB5.DE Yearly LT Debt VS Equity VS FCFUB5.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
UB5.DE Yearly Current Assets VS Current LiabilitesUB5.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.23% over the past year.
UB5 shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.63% yearly.
Looking at the last year, UB5 shows a small growth in Revenue. The Revenue has grown by 0.08% in the last year.
Measured over the past years, UB5 shows a small growth in Revenue. The Revenue has been growing by 3.62% on average per year.
EPS 1Y (TTM)1.23%
EPS 3Y-7.93%
EPS 5Y-1.63%
EPS Q2Q%14.44%
Revenue 1Y (TTM)0.08%
Revenue growth 3Y6.36%
Revenue growth 5Y3.62%
Sales Q2Q%3.64%

3.2 Future

Based on estimates for the next years, UB5 will show a small growth in Earnings Per Share. The EPS will grow by 5.38% on average per year.
The Revenue is expected to grow by 4.04% on average over the next years.
EPS Next Y9.71%
EPS Next 2Y10.24%
EPS Next 3Y10.36%
EPS Next 5Y5.38%
Revenue Next Year3.65%
Revenue Next 2Y4.04%
Revenue Next 3Y4.04%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
UB5.DE Yearly Revenue VS EstimatesUB5.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10B 20B 30B
UB5.DE Yearly EPS VS EstimatesUB5.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.97, the valuation of UB5 can be described as reasonable.
UB5's Price/Earnings ratio is a bit more expensive when compared to the industry. UB5 is more expensive than 70.37% of the companies in the same industry.
UB5's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.15.
UB5 is valuated reasonably with a Price/Forward Earnings ratio of 10.18.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UB5 is on the same level as its industry peers.
UB5 is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.12, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.97
Fwd PE 10.18
UB5.DE Price Earnings VS Forward Price EarningsUB5.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

UB5's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. UB5 is cheaper than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.81
EV/EBITDA N/A
UB5.DE Per share dataUB5.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.23
PEG (5Y)N/A
EPS Next 2Y10.24%
EPS Next 3Y10.36%

7

5. Dividend

5.1 Amount

UB5 has a Yearly Dividend Yield of 4.99%, which is a nice return.
Compared to an average industry Dividend Yield of 4.85, UB5 pays a bit more dividend than its industry peers.
UB5's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 4.99%

5.2 History

The dividend of UB5 has a limited annual growth rate of 4.83%.
Dividend Growth(5Y)4.83%
Div Incr Years1
Div Non Decr Years1
UB5.DE Yearly Dividends per shareUB5.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

58.35% of the earnings are spent on dividend by UB5. This is a bit on the high side, but may be sustainable.
UB5's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP58.35%
EPS Next 2Y10.24%
EPS Next 3Y10.36%
UB5.DE Yearly Income VS Free CF VS DividendUB5.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
UB5.DE Dividend Payout.UB5.DE Dividend Payout, showing the Payout Ratio.UB5.DE Dividend Payout.PayoutRetained Earnings

US BANCORP

FRA:UB5 (11/27/2025, 7:00:00 PM)

42.49

+1.22 (+2.94%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-16 2025-04-16/bmo
Earnings (Next)07-17 2025-07-17/bmo
Inst Owners82.08%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap66.28B
Revenue(TTM)27.58B
Net Income(TTM)5.91B
Analysts74.81
Price Target44.13 (3.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.99%
Yearly Dividend1.95
Dividend Growth(5Y)4.83%
DP58.35%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.82%
Min EPS beat(2)0.45%
Max EPS beat(2)3.19%
EPS beat(4)4
Avg EPS beat(4)2.1%
Min EPS beat(4)0.45%
Max EPS beat(4)3.29%
EPS beat(8)6
Avg EPS beat(8)1.46%
EPS beat(12)10
Avg EPS beat(12)1.56%
EPS beat(16)13
Avg EPS beat(16)5.45%
Revenue beat(2)0
Avg Revenue beat(2)-1.59%
Min Revenue beat(2)-1.88%
Max Revenue beat(2)-1.3%
Revenue beat(4)0
Avg Revenue beat(4)-1.24%
Min Revenue beat(4)-1.88%
Max Revenue beat(4)-0.36%
Revenue beat(8)0
Avg Revenue beat(8)-1.17%
Revenue beat(12)1
Avg Revenue beat(12)-1.26%
Revenue beat(16)3
Avg Revenue beat(16)-1.13%
PT rev (1m)-21.3%
PT rev (3m)-19.12%
EPS NQ rev (1m)-0.09%
EPS NQ rev (3m)2.6%
EPS NY rev (1m)-0.7%
EPS NY rev (3m)-0.25%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-0.11%
Revenue NY rev (1m)-0.72%
Revenue NY rev (3m)-0.57%
Valuation
Industry RankSector Rank
PE 11.97
Fwd PE 10.18
P/S 2.81
P/FCF 6.81
P/OCF 6.81
P/B 1.31
P/tB 1.9
EV/EBITDA N/A
EPS(TTM)3.55
EY8.35%
EPS(NY)4.17
Fwd EY9.83%
FCF(TTM)6.24
FCFY14.68%
OCF(TTM)6.24
OCFY14.68%
SpS15.12
BVpS32.41
TBVpS22.4
PEG (NY)1.23
PEG (5Y)N/A
Graham Number50.88
Profitability
Industry RankSector Rank
ROA 0.87%
ROE 10.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 21.62%
GM N/A
FCFM 41.24%
ROA(3y)0.82%
ROA(5y)0.92%
ROE(3y)10.02%
ROE(5y)10.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-13.56%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 1.23
Debt/FCF 6.4
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 190.78%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC14.05%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)247.31%
Profit Quality(5y)190.42%
High Growth Momentum
Growth
EPS 1Y (TTM)1.23%
EPS 3Y-7.93%
EPS 5Y-1.63%
EPS Q2Q%14.44%
EPS Next Y9.71%
EPS Next 2Y10.24%
EPS Next 3Y10.36%
EPS Next 5Y5.38%
Revenue 1Y (TTM)0.08%
Revenue growth 3Y6.36%
Revenue growth 5Y3.62%
Sales Q2Q%3.64%
Revenue Next Year3.65%
Revenue Next 2Y4.04%
Revenue Next 3Y4.04%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y33.46%
FCF growth 3Y4.53%
FCF growth 5Y18.19%
OCF growth 1Y33.46%
OCF growth 3Y4.53%
OCF growth 5Y18.19%

US BANCORP / UB5.DE FAQ

What is the ChartMill fundamental rating of US BANCORP (UB5.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to UB5.DE.


What is the valuation status of US BANCORP (UB5.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to US BANCORP (UB5.DE). This can be considered as Fairly Valued.


What is the profitability of UB5 stock?

US BANCORP (UB5.DE) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for UB5 stock?

The Earnings per Share (EPS) of US BANCORP (UB5.DE) is expected to grow by 9.71% in the next year.


Is the dividend of US BANCORP sustainable?

The dividend rating of US BANCORP (UB5.DE) is 7 / 10 and the dividend payout ratio is 58.35%.